20-HETE

20-hete is a lipid of Fatty Acyls (FA) class. 20-hete is associated with abnormalities such as Cyst, Kidney Diseases, Kidney Failure, Chronic, Cystic Kidney Diseases and Simple renal cyst. The involved functions are known as Phosphorylation, inhibitors, Hypertrophy, Epithelial Cell Proliferation and Anabolism. 20-hete often locates in Mouse Kidney, Microsomes, Tissue membrane, Body tissue and Cytoplasmic matrix. The associated genes with 20-HETE are CYP4F3 gene, PKHD1 gene, Transgenes, P4HTM gene and CYP2E1 gene. The related lipids are Promega, enterodiol, Fatty Acids, hexanoic acid and U 73343. The related experimental models are Mouse Model, Knock-out, Streptozotocin Diabetes, Transgenic Model and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of 20-HETE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 20-HETE?

20-HETE is suspected in Hypertensive disease, Renal tubular disorder, endothelial dysfunction, Renal glomerular disease, Ischemia, Cerebral Vasospasm and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 20-HETE

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Hypotension D007022 41 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Per page 10 20 50 | Total 33

PubChem Associated disorders and diseases

What pathways are associated with 20-HETE

Lipid pathways are not clear in current pathway databases. We organized associated pathways with 20-HETE through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 20-HETE?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 20-HETE?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 20-HETE?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 20-HETE?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 20-HETE?

Mouse Model

Mouse Model are used in the study '20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease.' (Park F et al., 2008), Mouse Model are used in the study 'Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.' (Alexanian A et al., 2009) and Mouse Model are used in the study 'Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.' (Harder DR and Roman RJ, 2006).

Knock-out

Knock-out are used in the study 'Effects of 20-HETE on Na+ transport and Na+ -K+ -ATPase activity in the thick ascending loop of Henle.' (Yu M et al., 2007) and Knock-out are used in the study 'Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.' (Williams JM et al., 2007).

Streptozotocin Diabetes

Streptozotocin Diabetes are used in the study 'Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.' (Chen YJ et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 20-HETE

Download all related citations
Per page 10 20 50 100 | Total 571
Authors Title Published Journal PubMed Link
Seki T et al. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis. 2005 Biol. Pharm. Bull. pmid:16141533
Ward NC et al. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. 2005 Free Radic. Biol. Med. pmid:15780761
Miyata N et al. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke. 2005 J. Pharmacol. Exp. Ther. pmid:15831442
Silverstein DM et al. Parathormone sensitivity and responses to protein kinases in subclones of opossum kidney cells. 2005 Pediatr. Nephrol. pmid:15834620
Randriamboavonjy V et al. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. 2005 Cardiovasc. Res. pmid:15639488
Zhang F et al. Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats. 2005 Hypertension pmid:15569854
McCarthy ET et al. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. 2005 Kidney Int. pmid:15610238
Wang J et al. Effects of high-salt diet on CYP450-4A omega-hydroxylase expression and active tone in mesenteric resistance arteries. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15576442
Zhang F et al. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. 2005 Cell Res. pmid:16212878
Miyata N and Roman RJ Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. 2005 J Smooth Muscle Res pmid:16258232
Yaghini FA et al. Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth. 2005 Hypertension pmid:15897359
Huang H et al. Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats. 2005 Am. J. Physiol. Renal Physiol. pmid:15998843
Takeuchi K et al. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15964920
Bolad I and Delafontaine P Endothelial dysfunction: its role in hypertensive coronary disease. 2005 Curr. Opin. Cardiol. pmid:15956822
Dahly-Vernon AJ et al. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. 2005 Hypertension pmid:15723968
Wang H et al. Glomerular cytochrome P-450 and cyclooxygenase metabolites regulate efferent arteriole resistance. 2005 Hypertension pmid:16230518
Sarkis A et al. Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus. 2005 Am. J. Physiol. Renal Physiol. pmid:16014574
Gross GJ et al. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. 2005 Cardiovasc. Res. pmid:15993870
Chuang SS et al. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. 2004 J. Biol. Chem. pmid:14660610
Dos Santos EA et al. Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis. 2004 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15031141
Lee SJ et al. Cytochrome P-450 metabolites in endothelin-stimulated cardiac hormone secretion. 2004 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:14715489
Nakamura T et al. Design and synthesis of 1-(4-benzoylphenyl)imidazole derivatives as new potent 20-HETE synthase inhibitors. 2004 Bioorg. Med. Chem. Lett. pmid:15454216
Caron N et al. Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases. 2004 Clin. Exp. Pharmacol. Physiol. pmid:15554908
Ikari A et al. Activation of Na+-independent Mg2+ efflux by 20-hydroxyeicosatetraenoic acid in rat renal epithelial cells. 2004 Jpn. J. Physiol. pmid:15631697
Wang JS et al. Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues. 2004 J. Pharmacol. Exp. Ther. pmid:15269250
Ishizuka T et al. [Role of androgens in the renal production of 20-hydroxyeicosatetraenoic acid in spontaneously hypertensive rats]. 2004 Nihon Jinzo Gakkai Shi pmid:15570896
Gross ER et al. Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel. 2004 J. Mol. Cell. Cardiol. pmid:15572055
Poloyac SM et al. The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney. 2004 Drug Metab. Dispos. pmid:15205388
Hoagland KM et al. Elevated BSC-1 and ROMK expression in Dahl salt-sensitive rat kidneys. 2004 Hypertension pmid:14967839
Jiang M et al. Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels. 2004 Circ. Res. pmid:14670847
Nakamura T et al. Pyrazole derivatives as new potent and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors. 2004 Bioorg. Med. Chem. pmid:15519164
Scotland RS et al. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. 2004 Circ. Res. pmid:15499026
Yu M et al. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. 2004 Eur. J. Pharmacol. pmid:14985052
Imig JD 20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis? 2004 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15191921
Kaduce TL et al. 20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. 2004 J. Biol. Chem. pmid:14612451
Xu F et al. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. 2004 J. Pharmacol. Exp. Ther. pmid:14634044
Peppiatt C and Attwell D Neurobiology: feeding the brain. 2004 Nature pmid:15356612
Mulligan SJ and MacVicar BA Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. 2004 Nature pmid:15356633
Zhao X et al. P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid. 2004 J. Pharmacol. Exp. Ther. pmid:15316085
Ward NC et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. 2004 Circulation pmid:15262846
Li D et al. Dietary K intake regulates the response of apical K channels to adenosine in the thick ascending limb. 2004 Am. J. Physiol. Renal Physiol. pmid:15265768
Kaide J et al. Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction. 2004 Hypertension pmid:15226275
Sarkis A et al. Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension. 2004 Curr. Opin. Nephrol. Hypertens. pmid:15202615
Fuloria M et al. 20-hydroxyeicosatetraenoic acid is a vasoconstrictor in the newborn piglet pulmonary microcirculation. 2004 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:15075246
Lombard JH et al. Evaluation of cytochrome P450-4A omega-hydroxylase and 20-hydroxyeicosatetraenoic acid as an O2 sensing mechanism in the microcirculation. 2004 Meth. Enzymol. pmid:15063671
Zhang F et al. Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli. 2004 Am. J. Physiol. Heart Circ. Physiol. pmid:15130884
Ferreri NR et al. Renal COX-2, cytokines and 20-HETE: tubular and vascular mechanisms. 2004 Curr. Pharm. Des. pmid:14965324
Laffer CL et al. 20-HETE and circulating insulin in essential hypertension with obesity. 2004 Hypertension pmid:14707157
Rivera J et al. Measurement of 20-hydroxyeicosatetraenoic acid in human urine by gas chromatography-mass spectrometry. 2004 Clin. Chem. pmid:14709657
Nakamura T et al. Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors. 2004 Bioorg. Med. Chem. Lett. pmid:14698153
Nithipatikom K et al. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. 2004 Circ. Res. pmid:15388642
Little JM et al. Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. 2004 J. Lipid Res. pmid:15231852
Phadtare S et al. Candida bombicola cells immobilized on patterned lipid films as enzyme sources for the transformation of arachidonic acid to 20-HETE. 2003 Nov-Dec Biotechnol. Prog. pmid:14656138
Grider JS et al. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. 2003 Eur. J. Pharmacol. pmid:12892837
Hoagland KM et al. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. 2003 Hypertension pmid:12623982
Cheng MK et al. Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase. 2003 Am. J. Physiol. Renal Physiol. pmid:12419775
Laffer CL et al. 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension. 2003 Hypertension pmid:12623983
Randriamboavonjy V et al. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. 2003 Hypertension pmid:12623999
Skott O Androgen-induced activation of 20-HETE production may contribute to gender differences in blood pressure regulation. 2003 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12626366
Ren Y et al. Glomerular autacoids stimulated by bradykinin regulate efferent arteriole tone. 2003 Kidney Int. pmid:12631079
Yu M et al. 20-hydroxyeicosatetraenoic acid (20-HETE): structural determinants for renal vasoconstriction. 2003 Bioorg. Med. Chem. pmid:12788354
Basora N et al. 20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells. 2003 J. Biol. Chem. pmid:12794071
Bolcato CA et al. Determination of 20-hydroxyeicosatetraenoic acid in microsomal incubates using high-performance liquid chromatography-mass spectrometry (HPLC-MS). 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12954388
Quilley J et al. Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness. 2003 J. Pharmacol. Exp. Ther. pmid:12954811
Cambj-Sapunar L et al. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. 2003 Stroke pmid:12677022
Grates HE et al. Quantification of 20-hydroxyeicosatetraenoic acid by colorimetric competitive enzyme linked immunosorbent assay. 2003 J. Biosci. pmid:12682433
Wang MH et al. Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats. 2003 Am. J. Physiol. Renal Physiol. pmid:12684227
Kaide J et al. Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries. 2003 Am. J. Physiol. Renal Physiol. pmid:12388396
Carroll MA et al. Regulation of renal microvascular 20-hydroxyeicosatetraenoic acid (20-HETE) levels. 2003 Adv. Exp. Med. Biol. pmid:12751736
Carroll MA et al. Cytochrome P450 arachidonic acid metabolites modulate renal tubular function. 2003 Adv. Exp. Med. Biol. pmid:12751738
Cloutier M et al. 20-HETE inotropic effects involve the activation of a nonselective cationic current in airway smooth muscle. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12754190
Goodman AI et al. Functional expression of human heme oxygenase-1 gene in renal structure of spontaneously hypertensive rats. 2003 Exp. Biol. Med. (Maywood) pmid:12709568
Moreno JJ Cyclooxygenase and cytochrome P-450 pathways induced by fetal calf serum regulate wound closure in 3T6 fibroblast cultures through the effect of prostaglandin E2 and 12 and 20 hydroxyeicosatetraenoic acids. 2003 J. Cell. Physiol. pmid:12599212
Nakagawa K et al. Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. 2003 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12531784
Laffer CL et al. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension. 2003 Circulation pmid:12566369
Bellamine A et al. Characterization of the CYP4A11 gene, a second CYP4A gene in humans. 2003 Arch. Biochem. Biophys. pmid:12464262
Amaral SL et al. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12521947
Hoagland KM et al. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. 2003 Hypertension pmid:12874093
Quilley J and Chen YJ Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. 2003 Hypertension pmid:12900435
Hookes J Asian Federation of Medicinal Chemistry (AFMC) - Fifth International Medicinal Chemistry Symposium. 14-17 October 2003, Kyoto, Japan. 2003 IDrugs pmid:15270004
Nakayama K et al. 20-Hydroxyeicosatetraenoic acid potentiates contractile activation of canine basilar artery in response to stretch via protein kinase Calpha-mediated inhibition of calcium-activated potassium channel. 2003 Adv. Exp. Med. Biol. pmid:15098687
Widstrom RL et al. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase. 2003 Biochemistry pmid:14529287
Ishizuka T et al. Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney. 2003 Hypertens. Res. pmid:14714586
Looft-Wilson RC et al. 20-HETE pathway antagonists inhibit rat small mesenteric artery tone. 2002 Microvasc. Res. pmid:12204659
Kehl F et al. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11893593
Xu F et al. Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega-hydroxylase activity. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12185006
Wang MH et al. Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11792647
Roman RJ P-450 metabolites of arachidonic acid in the control of cardiovascular function. 2002 Physiol. Rev. pmid:11773611
Gu RM and Wang WH Arachidonic acid inhibits K channels in basolateral membrane of the thick ascending limb. 2002 Am. J. Physiol. Renal Physiol. pmid:12167590
Bełtowski J et al. The opposite effects of cyclic AMP-protein kinase a signal transduction pathway on renal cortical and medullary Na+,K+-ATPase activity. 2002 J. Physiol. Pharmacol. pmid:12120897
Frisbee JC et al. Integration of hypoxic dilation signaling pathways for skeletal muscle resistance arteries. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12121842
Zemaitis M et al. Identification of omega hydroxy fatty acids in biological samples as their pentafluoropropyl derivatives by gas chromatography/mass spectrometry with positive and negative ion detection. 2002 Rapid Commun. Mass Spectrom. pmid:12125016
Hercule H and Oyekan A Renal cytochrome p450 oxygenases and preglomerular vascular response to arachidonic acid and endothelin-1 following ischemia/reperfusion. 2002 J. Pharmacol. Exp. Ther. pmid:12130736
Frisbee JC and Lombard JH Parenchymal tissue cytochrome P450 4A enzymes contribute to oxygen-induced alterations in skeletal muscle arteriolar tone. 2002 Microvasc. Res. pmid:11969311
Alonso-Galicia M et al. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12069931
Zhu D et al. CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. 2002 J. Appl. Physiol. pmid:12070222
Zhang F et al. Arachidonate CYP hydroxylases of kidney contribute to formation of hypertension and maintenance of blood pressure. 2002 Acta Pharmacol. Sin. pmid:12060522
Marji JS et al. Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. 2002 Am. J. Physiol. Renal Physiol. pmid:12060587
Obara K et al. 20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC alpha-mediated inhibition of KCa channel. 2002 Br. J. Pharmacol. pmid:12466247
Li PL et al. Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11893556